Skip to main content
. 2017 Aug 7;10(8):609–618. doi: 10.1177/1756283X17722745

Table 1.

Lower limit of quantitation, upper limit of quantitation, sample input volume, and processing volume of the four cobas HBV assays*.

Platform* Quantitative standard control
(type)
Linear range Workflow
LLOQ
(IU/ml)
ULOQ
(IU/ml)
Sample processing volume
(µl)
Type of sample prep Maximum walk away time
(h)
Sample processing time$ (h) Hands on time per 8 h shift (h) Detection time
(h)
Interventions per 8 h
(n)
Time to first results [h (n)] Throughput
in 8 h
(n)
HPS/CTM Competitive 29 1.1E + 08 500 Manual 3 2 2.5 3 N/A 5 (48) 96
CAP/CTM Competitive 20 1.7E + 08 650 Automated 2.5 2 0.5 3 4 5.5 (96) 96
cobas 4800 Noncompetitive 10 1.0E + 09 200 or 400 Automated 2.7 3 0.5 1.5 5 <5 (96) 192
cobas 6800 Noncompetitive 10 1.0E + 09 200 or 500 Automated 8 1.5 0.5 1.5 3 <3.5 (96) 384
cobas 8800 Noncompetitive 10 1.0E + 09 200 or 500 Automated 4 1.5 1 1.5 4 <3.5 (96) 960
*

Corresponding assays for each platform: COBAS TaqMan HBV test for use with the High Pure System (HPS/CTM); COBAS AmpliPrep/COBAS TaqMan HBV v2 test using the COBAS AmpliPrep Instrument for automated specimen processing and the COBAS TaqMan Analyzer (CAP/CTM); cobas HBV test for use on the cobas 4800 System (cobas 4800); cobas HBV test for use on the cobas 6800/8800 Systems (cobas 6800/8800).

$

Sample processing time includes sample extraction and purification and polymerase chain reaction setup.

Extra waste removal step compared with cobas 6800.

HBV, hepatitis B virus; LLOQ, lower limit of quantitation; ULOQ, upper limit of quantitation.